1. Home
  2. ZBH

as of 12-08-2025 3:43pm EST

$92.68
$1.55
-1.64%
Stocks Health Care Industrial Specialties Nasdaq

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

Chart Type:
Time Range:
Founded: 1927 Country:
United States
United States
Employees: 17000 City: WARSAW
Market Cap: 18.7B IPO Year: N/A
Target Price: $108.56 AVG Volume (30 days): 2.0M
Analyst Decision: Buy Number of Analysts: 19
Dividend Yield:
1.03%
Dividend Payout Frequency: Quarterly
EPS: 4.03 EPS Growth: -23.28
52 Week Low/High: $85.33 - $114.44 Next Earning Date: 11-05-2025
Revenue: $8,010,900,000 Revenue Growth: 5.47%
Revenue Growth (this year): 8.2% Revenue Growth (next year): 5.92%

AI-Powered ZBH Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 77.85%
77.85%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of Zimmer Biomet Holdings Inc. (ZBH)

Yi Sang

Group President, Asia Pacific

Sell
ZBH Sep 11, 2025

Avg Cost/Share

$103.59

Shares

1,200

Total Value

$124,302.00

Owned After

18,584

SEC Form 4

Latest Zimmer Biomet Holdings Inc. News

ZBH Breaking Stock News: Dive into ZBH Ticker-Specific Updates for Smart Investing

All ZBH News

Share on Social Networks: